Topic Hub
28 clinically reviewed articles, written and peer-reviewed by the HealthRX.com Medical Team.
Explore
Showing 28 of 28 clinical reviews.
A detailed clinical review of the pioglitazone and acetaminophen drug interaction, covering hepatotoxicity overlap, CYP2C8 metabolism, monitoring parameters, dose guidance, and patient counseling. Reviewed by the HealthRX medical team.
Read clinical reviewCan you take Actos (pioglitazone) with apixaban? A physician-reviewed guide covering the CYP3A4/P-gp mechanism, severity rating, monitoring labs, dose adjustments, and patient counseling.
Read clinical reviewClinical guide to combining pioglitazone (Actos) with benzodiazepines. Covers CYP metabolism overlap, fluid retention risks, monitoring protocols, and dose adjustments backed by primary literature.
Read clinical reviewClinical review of the pioglitazone-bupropion drug interaction covering CYP2C8/CYP2D6 metabolism, seizure risk, fluid retention, weight effects, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewClopidogrel's acyl glucuronide metabolite inhibits CYP2C8, raising pioglitazone levels by up to 45%. Learn the mechanism, clinical severity, dose adjustments, and monitoring required when combining these drugs.
Read clinical reviewCan you take Actos (pioglitazone) with diphenhydramine? Review the pharmacokinetic and pharmacodynamic interaction profile, CYP metabolism overlap, severity rating, monitoring parameters, and dose-adjustment guidance.
Read clinical reviewCan you take Actos (pioglitazone) with estradiol HRT? A physician-reviewed guide covering the CYP2C8 metabolism overlap, fluid retention risks, VTE considerations, dose adjustments, and monitoring labs.
Read clinical reviewA detailed clinical review of the pioglitazone and finasteride drug interaction, covering mechanism, severity, monitoring, dose adjustment, and patient counseling with primary literature citations.
Read clinical reviewClinical review of pioglitazone and gabapentin drug interactions covering CYP metabolism, fluid retention overlap, edema risk, weight gain, and monitoring protocols for patients on both medications.
Read clinical reviewClinical review of the drug interaction between pioglitazone (Actos) and hormonal contraceptives, covering CYP3A4 induction, pharmacokinetic data, contraceptive efficacy, and practical monitoring guidance.
Read clinical reviewCan you take pioglitazone (Actos) with levothyroxine? Learn about the interaction mechanism, clinical significance, dose timing, monitoring labs, and what your doctor should know.
Read clinical reviewA physician-reviewed guide to the pioglitazone-metformin drug interaction: mechanisms, safety, dosing, monitoring, and patient counseling for type 2 diabetes management.
Read clinical reviewClinical guide to combining pioglitazone (Actos) with opioid analgesics including oxycodone, hydrocodone, and tramadol. Covers CYP metabolism, monitoring, dose adjustment, and safety.
Read clinical reviewClinical guide to combining pioglitazone (Actos) with proton pump inhibitors like omeprazole and pantoprazole. Covers CYP metabolism, severity, dose adjustments, and monitoring.
Read clinical reviewA clinician-reviewed guide to the pioglitazone, prednisone drug interaction, covering mechanisms, severity, blood-glucose monitoring, dose adjustments, and patient counseling for people with type 2 diabetes on corticosteroids.
Read clinical reviewA clinical deep-dive into the pioglitazone and pregabalin drug interaction, covering pharmacodynamic mechanisms, edema and weight-gain risk, CNS sedation, monitoring protocols, and dose-adjustment guidance backed by primary literature.
Read clinical reviewA physician-reviewed guide to the pioglitazone and progesterone HRT drug interaction, covering CYP metabolism, fluid retention risk, blood glucose effects, monitoring thresholds, and dose-adjustment strategies.
Read clinical reviewClinical review of the pioglitazone-rivaroxaban drug interaction, covering CYP3A4 induction, P-gp effects, severity ratings, monitoring protocols, and dose-adjustment guidance.
Read clinical reviewClinical review of the pioglitazone-rosuvastatin drug interaction, covering CYP2C8 metabolism, OATP1B1 transport, muscle risk, fluid retention, and evidence-based monitoring protocols.
Read clinical reviewCan you take Actos (pioglitazone) with sildenafil? A physician-reviewed guide covering the pharmacokinetic and pharmacodynamic interaction profile, monitoring parameters, and dose adjustments.
Read clinical reviewA physician-reviewed guide to the pioglitazone, simvastatin drug interaction, covering mechanism, severity, monitoring, dose adjustment, and patient counseling for safe co-administration.
Read clinical reviewA clinician-reviewed guide to the pioglitazone-SSRI interaction covering CYP2C8 pharmacokinetics, serotonin syndrome risk, glucose monitoring, and patient counseling for sertraline and escitalopram co-administration.
Read clinical reviewA physician-reviewed guide to the pioglitazone, tadalafil drug interaction: mechanism, hypotension risk, monitoring parameters, dose considerations, and patient counseling based on FDA labels and primary literature.
Read clinical reviewCan you take Actos (pioglitazone) with testosterone? A physician-reviewed guide to the drug interaction, including mechanism, severity, monitoring labs, and dose adjustments.
Read clinical reviewBoard-certified clinician guide to the pioglitazone-trazodone drug interaction. Covers CYP2C8 metabolism, hypoglycemia risk, edema monitoring, severity ratings, and dose-adjustment strategies.
Read clinical reviewClinical guide to the pioglitazone-warfarin drug interaction covering CYP2C9 mechanism, INR monitoring protocols, dose adjustment, and patient counseling for type 2 diabetes patients on anticoagulation.
Read clinical reviewA clinician-reviewed guide to the pioglitazone, zolpidem drug interaction: mechanism, severity, monitoring parameters, dose guidance, and patient counseling based on FDA labeling and primary literature.
Read clinical reviewClinical review of the pioglitazone and SNRI interaction covering CYP2C8 inhibition by duloxetine, blood glucose effects, edema risk, monitoring parameters, and dose-adjustment strategies.
Read clinical review